NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

  • NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets
  • Lotus Pharmaceuticals will acquire worldwide rights for NRX-101 for S-TRBD and will be responsible for

GWGHQ FINAL DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GWG Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GWGHQ

NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of GWG Holdings, Inc. L Bonds or Preferred Stock of GWG (“GWG securities”) (OTC: GWGHQ) between December 23, 2017 and …

MPW FINAL DEADLINE NOTICE: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Medical Properties Trust, Inc. Investors with Losses Over $100K to Secure Counsel Before Important June 12 Deadline in Securities Class Action – MPW

NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Medical Properties Trust, Inc. (“MPT”) (NYSE: MPW) between July 15, 2019 and February 22, 2023, both …

1 2 3 238